BioSpace News Archive

Paragonix Technologies, Inc. will present the Paragonix SherpaPak™ Cardiac Transport System product line at Medline Industries, Inc. Booths 45 and 46 during the 2018 American Association of Tissue Banks (AATB) Annual Meeting held in Dallas, TX, from 9 to 12 October, 2018.

“Pharmacists are the general public’s most accessible health care professional…”

ADVANZ PHARMA represents the Company’s vision to go beyond expectations to bring sustainable value to customers, healthcare providers, and patients

Scientific publication reports preclinical results showing precision oncology opportunity for targeting SHP2 in genetically selected tumors

AVEO Oncology today announced that updated interim data from the Phase 2 portion of the TiNivo trial of tivozanib and nivolumab (OPDIVO®) in advanced renal cell carcinoma will be presented at the European Society of Medical Oncology (ESMO) 2018 Annual Congress being held October 19-23, 2018 in Munich, Germany.

Verastem, Inc. today announced that the National Comprehensive Cancer Network® (NCCN®) added COPIKTRA™ (duvelisib) capsules to the Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

ContraVir Pharmaceuticals COO Brings Extensive Infectious Disease-focused Drug Development Experience to Appili’s Board

Torque, an immuno-oncology company developing first-in-class Deep Primed™ T Cell Therapeutics to direct immune power deep within the tumor microenvironment, announced today the appointment of Karsten Sauer, PhD, as Vice President,

Research presented includes expanded pivotal trial data set on pipeline compound larotrectinib for TRK fusion cancer across multiple tumor types in adult and pediatric patient

Novel anti-metallothionein antibody, UC1MT, has the potential to become a first-in-class treatment for a range of inflammatory and autoimmune disorders